Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Ovarian Neoplasms × neratinib × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Neoplasms 3 Neoplasm Metastasis 3 Advanced Malignant Solid Tumors 3 Thrombocytosis 1 Stomach Neoplasms 1 Solid Tumor 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Blast Crisis 1 Anemia 1

Interventions

Paclitaxel 61 Carboplatin 57 pembrolizumab 30 Cyclophosphamide 29 Bevacizumab 25 Cisplatin 24 liposomal doxorubicin 23 Gemcitabine 19 Topotecan 17 fludarabine 15 Docetaxel 14 olaparib 13 Taxes 13 niraparib 12 Nivolumab 12 veliparib 11 Doxorubicin 11 Albumin-Bound Paclitaxel 9 fludarabine phosphate 8 Filgrastim 8 sargramostim 7 durvalumab 7 aldesleukin 7 Peripheral Blood Stem Cell Transplantation 7 Oxaliplatin 7 Fluorouracil 7 Melphalan 6 Magnetic Resonance Spectroscopy 6 Leucovorin 6 Fulvestrant 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04502602 2025-05-04

iNNOVATE

Virginia Commonwealth University

Phase 1 Active not recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡